Where is the live CopyMark page for USPTO serial 79219645?

The live record is at https://getcopymark.com/trademark/79219645. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79219645?

According to the public USPTO record for serial number 79219645, the listed owner(s) include: Nanobiotix, Nanobiotix, Nanobiotix.

What is USPTO serial number 79219645?

Serial number 79219645 is the USPTO application identifier for the mark Serial No. 79219645. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79219645?

Serial No. 79219645 (79219645) currently shows USPTO status code 709 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79219645?

The public record lists International Classes: 005, 010. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79219645 Serial# 79219645 | status 709; last event INNT | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79219645?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Goods and services

Class	Description	Status	First use
005	Pharmaceutical products, namely, agents for tumor treatment for use only in relation to radiotherapy; medicines for human use for use only in relation to radiotherapy for cancer treatment; healthcare products, namely, pharmaceutical products for cancer treatment for use only in relation to radiotherapy; drugs for medical use for cancer treatment for use only in relation to radiotherapy; preparations for medical use for use only in relation to radiotherapy, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use for use only in relation to radiotherapy for cancer treatment; medical preparations for medical or pharmaceutical use consisting of medication delivery agents in the form of tablets and capsules for cancer treatment for use only in relation to radiotherapy; chemical-pharmaceutical products consisting in tablets or injectable products for cancer treatment for use only in relation to radiotherapy; diagnostic biomarking reagents for medical use for use only in relation to radiotherapy	SECTION 71 - CANCELLED	—
010	Diagnostic apparatus for medical use, namely, X-ray apparatus for medical use; radiology screens for medical use	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 5, 2025	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Nov 18, 2025	INTS	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB	—
Nov 18, 2025	INPC	INVALIDATION PROCESSED	—
Jun 18, 2025	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Oct 18, 2024	C71T	CANCELLED SECTION 71	—
Aug 11, 2018	FINV	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Jul 16, 2018	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Jul 16, 2018	FIMP	FINAL DISPOSITION PROCESSED	—
Jul 3, 2018	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Apr 3, 2018	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 27, 2018	GPNX	NOTIFICATION PROCESSED BY IB	—
Jan 16, 2018	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 10, 2018	OPNS	NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB	—
Jan 10, 2018	OP2R	NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB	—
Dec 27, 2017	NPUB	NOTICE OF PUBLICATION	—
Dec 9, 2017	RFNT	REFUSAL PROCESSED BY IB	—
Dec 5, 2017	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Dec 4, 2017	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Dec 2, 2017	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Dec 2, 2017	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2017	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Nov 21, 2017	RFRR	REFUSAL PROCESSED BY MPU	—
Nov 7, 2017	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Nov 6, 2017	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2017	MAFR	APPLICATION FILING RECEIPT MAILED	—
Nov 3, 2017	DOCK	ASSIGNED TO EXAMINER	—
Oct 31, 2017	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Oct 26, 2017	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

Serial No. 79219645